April 8 (Reuters) - Lab equipment maker Waters said on Wednesday the U.S. Food and Drug Administration has cleared its ...

Waters Corporation (NYSE: WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV ...

FDA feedback enables Corbus to proceed with proposed registrational study design and endpoints to support potential accelerated approval in ...

Home testing kits that screen for cervical cancer risk could be a game-changer for reducing health inequalities for ...

ANSWER: HPV is the cause of cervical cancer in women and head and neck cancer in men. Although there are many different types ...

The FDA has agreed on the design of two randomized phase 3 trials evaluating CRB-701, a next-generation Nectin-4-targeted ...

It’s easy to brush off certain symptoms — but ignoring them could be a big mistake. Cervical cancer is a slow-burner that often flies under the radar in its early stages, quietly growing for months or ...

Consider this a public cervix announcement. The American Cancer Society made a dire prediction — nearly 13,400 cases of invasive cervical cancer will be diagnosed this year and about 4,300 women will ...

Transient HPV is the norm, whereas persistent high-risk HPV over years drives cervical dysplasia and malignant transformation, supporting longitudinal surveillance when high-risk types are identified.

Add Yahoo as a preferred source to see more of our stories on Google. Teal Health’s Teal Wand enables people ages 25-65 years old to screen for cervical cancer at home — no speculum or stirrups ...

A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV ...

The EMAC Cervical Cancer Foundation, in collaboration with its partners, is proud to announce the successful conclusion of ...